Artificial Intelligence–Driven Design of Selective Apoptosis Re-activators Targeting Unendurable Cancer Proteins
Keywords:
Artificial Intelligence (AI), Apoptosis Re activators, Unendurable Cancer Targets, Computational Drug Design, Protein Brigands Interaction, Cancer Therapeutic, Machine Learning in Oncology, Targeted TherapyAbstract
Malignant cells lack appropriate binding sites and adaptive resistance mechanisms, the creation of specific apoptotic re-activators for unendurable cancer proteins continues to be a major problem in precision oncology. Recently, the discovery of new molecular scaffolds, the prediction of protein–ligand interactions, and the optimization of therapeutic specificity have all been made possible by artificial intelligence (AI)-driven methods. In this work, we propose selective apoptotic re-activators that target unendurable oncogenic proteins like KRAS, MYC, and mutant p53 by utilizing AI-powered computational platforms, such as generative modelling, virtual screening, and deep learning-based protein structure prediction. High-resolution structural data, ligand-protein docking simulations, and multi-parametric optimization for binding affinity, selectivity, and pharmacokinetic characteristics are all included into the suggested methodology. Effective reactivation of apoptotic pathways, such as caspase-3/7 activation and mitochondrial membrane depolarization, while sparing normal cells is demonstrated by in vitro validation in apoptosis-resistant cancer cell lines. Additionally, negligible off-target interactions are shown by in silico calculations, suggesting great treatment specificity. According to mechanistic studies, the AI-designed compounds overcome compensatory anti-apoptotic pathways and disrupt protein–protein interactions essential for oncogenic survival in order to restore apoptotic signaling. This comprehensive AI-driven system offers a platform for the logical design of next-generation treatments in refractory tumors and speeds up the identification of promising drug candidates against targets that were previously untreatable. The results show how computational intelligence and experimental validation can be used to overcome major drug development barriers and provide a promising path toward precision-targeted cancer treatments. Overall, this work opens the door for translational applications in personalized oncology by establishing a strong paradigm for AI-guided drug design that permits the specific induction of apoptosis in resistant cancers.
References
1. Akinsanya, K., AlQuraishi, M., Boija, A. et al. Redefining druggable targets with artificial intelligence. Nat Biotechnol 43, 1416–1418 (2025). https://doi.org/10.1038/s41587-025-02770-1
2. Sikkander, A. M., Bassyouni, F., Yasmeen, K., Mishra, S. R., & Lakshmi, V. V. (2023). Synthesis of zinc oxide and lead nitrate nanoparticles and their applications: Comparative studies of bacterial and fungal (E. coli, A. niger). Journal of Applied Organometallic Chemistry, 3 (4), 255–267. https://doi.org/10.48309/JAOC.2023.41588
3. Sikkander, A. R. M., Vedhi, C., & Manisankar, P. (2012). Electrochemical determination of calcium channel blocker drugs using multiwall carbon nanotube-modified glassy carbon electrode. International Journal of Industrial Chemistry, 3, 29. https://doi.org/10.1186/2228-5547-3-29
4. Sikkander, A. R. M., Meena, M., Yadav, H., Wahi, N., & Lakshmi, V. V. (2024). Appraisal of the impact of applying organometallic compounds in cancer therapy. Journal of Applied Organometallic Chemistry, 4(2), 145–166. https://doi.org/10.48309/JAOC.2024.433120.1154
5. Sikkander, A. R. M., Yadav, H., Meena, M., Wahi, N., & Kumar, K. (2024). A review of diagnostic nano stents: Part I. Journal of Chemical Reviews, 6(2), 138–180. https://doi.org/10.48309/JCR.2024.432947.1287
6. Mohamed Sikkander, A. R., Yadav, H., Meena, M., Wahi, N., & Kumar, K. (2024). A review of diagnostic nano stents: Part I. Journal of Chemical Reviews, 6(2), 138–180. https://doi.org/10.48309/jcr.2024.432947.1287
7. Soragni, A., Knudsen, E.S., O’Connor, T.N. et al. Acquired resistance in cancer: towards targeted therapeutic strategies. Nat Rev Cancer 25, 613–633 (2025). https://doi.org/10.1038/s41568-025-00824-9
8. Mohamed Sikkander, A. R., Yadav, H., Meena, M., & Lakshmi, V. V. (2024). A review of advances in the development of bioresorbable nano stents: Part II. Journal of Chemical Reviews, 6(3),304–330. https://doi.org/10.48309/jcr.2024.432944.1286
9. Sikkander, A. M. (2022). Intrathecal chemotherapy for blood cancer treatment. Zenodo. https://doi.org/10.5281/zenodo.7008901
10. Utilization of sodium montmorillonite clay for enhanced electrochemical sensing of amlodipine. (n.d.). Indian Journal of Chemistry. https://doi.org/10.56042/ijca.v55i5.11669
11. Sikkander, A. M. (2022). Assess of hydrazine sulphate (N₂H₆SO₄) in opposition for the majority of cancer cells. Acta Biology Forum, 1(1), 10–13. http://dx.doi.org/10.5281/zenodo.7008883
12. Sikkander, A. R. M. (2024). Ruthenium organometallic compounds in cancer treatment. Biomedical Engineering: Applications, Basis and Communications, 37(1). https://doi.org/10.4015/s1016237224300037
13. Wang, T., He, X., Li, M. et al. Ab initio characterization of protein molecular dynamics with AI2BMD. Nature 635, 1019–1027 (2024). https://doi.org/10.1038/s41586-024-08127-z
14. Sikkander, A. R. M., Tripathi, S. L., & Theivanathan, G. (2025). Extensive sequence analysis: Revealing genomic knowledge throughout various domains. In Elsevier eBooks (pp. 17–30). https://doi.org/10.1016/b978-0-443-30080-6.00007-9
15. Sikkander, A. (2022). Duct cancer evaluation in situ – Review. Zenodo. https://doi.org/10.5281/zenodo.7008689
16. Sikkander, M., & Nasri, N. S. (2014). Review on inorganic nanocrystals: Unique benchmark of nanotechnology. Moroccan Journal of Chemistry, 1(2). https://doi.org/10.48317/imist.prsm/morjchem-v1i2.1892
17. Rodrigues, J. J., Sikkander, A. R. M., Tripathi, S. L., Kumar, K., Mishra, S. R., & Theivanathan, G. (2025). Healthcare applications of computational genomics. In Elsevier eBooks (pp. 259–278). https://doi.org/10.1016/b978-0-443-30080-6.00012-2
18. Yadav, C. H., Revanuri, N., & Sikkander, A. R. M. (2025). Tungsten-based compounds: A new frontier in cancer diagnosis and therapy. Journal of Applied Organometallic Chemistry, 5(2), 149–167. https://doi.org/10.48309/JAOC.2025.479952.1270
19. Rodrigues, J. J., Sikkander, A. R. M., Tripathi, S. L., Kumar, K., Mishra, S. R., & Theivanathan, G. (2025). Artificial intelligence’s applicability in cardiac imaging. In Elsevier eBooks (pp. 181–195). https://doi.org/10.1016/b978-0-443-30080-6.00006-7
20. Sadybekov, A.V., Katritch, V. Computational approaches streamlining drug discovery. Nature 616, 673–685 (2023). https://doi.org/10.1038/s41586-023-05905-z
21. Carneiro, B.A., El-Deiry, W.S. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17, 395–417 (2020). https://doi.org/10.1038/s41571-020-0341-y
22. Carneiro, B.A., El-Deiry, W.S. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17, 395–417 (2020). https://doi.org/10.1038/s41571-020-0341-y
23. Sazonova, E. V., Yapryntseva, M. A., Pervushin, N. V., Tsvetcov, R. I., Zhivotovsky, B., & Kopeina, G. S. (2024). Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death. Cells, 13(5), 388. https://doi.org/10.3390/cells13050388
24. Pathak, A., Theagarajan, R., Rizqi, M.M. et al. AI-enabled drug and molecular discovery: computational methods, platforms, and translational horizons. Discov Mol 2, 32 (2025). https://doi.org/10.1007/s44345-025-00037-5
25. Yadav, C. H., Revanuri, N., & Sikkander, A. R. M. (2025). Organometallic compound phototoxicity against cancer cells. *Biomedical Engineering: Applications, Basis and Communications, 38(1). https://doi.org/10.4015/s1016237225500206
26. Mohamed Sikkander, A. R., Yadav, H., & Meena, M. (2024). The effectiveness of a nickel (II) complex containing 5-acetyl-N-(adamantan-2-yl) thiophene-2-carboxamide as a derivative for the drug isoniazid in relation to bacterial, cancer and tuberculosis activities. Advanced Journal of Chemistry, Section A, 7(5), 501–521. https://doi.org/10.48309/ajca.2024.443156.1490
27. Sikkander, A. M. (2022). Advancement of agricultural biotechnology in USA. International Journal of AgroChemistry. https://chemical.journalspub.info/index.php?journal=IJCPD&page=article&op=view&path%5B%5D=1299
28. Ramachandran, K., & Sikkander, A. M. (2021). Biomedical signal processing: Understanding its importance and several fundamental steps. Transaction on Biomedical Engineering Applications and Healthcare, 2(2), 15–16.
29. 21. Chegini, S., Sikkander, A. R. M., Masoudi, M., Ekhtari, H., Mojaver, E., & Jafari, H. (2026). A circular bioeconomy framework for biodegradable waste: Strategies and opportunities. Bioresources and Bioproducts, 2(1), 2. https://doi.org/10.3390/bioresourbioprod2010002
30. Kirkpatrick, P. (2025). Dealmakers seek to expand the druggable proteome. Biopharma Dealmakers. https://doi.org/10.1038/d43747-025-00094-2
31. Igney, F., Krammer, P. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2, 277–288 (2002). https://doi.org/10.1038/nrc776
32. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). Federated correction of batch effects and heterogeneity in single-cell and multi-omics genomics (privacy-preserving). World Journal of Applied Medical Sciences, 2(12), 24–30. https://doi.org/10.65336/wjams.2025.21204
33. Hiremath, G., Mohamed Sikkander, A. R., Upadhyay, R., Acharya, D., Singh, K. P., & Wahi, N. (2025). Safety and efficacy of drug-eluting stents improved dramatically with application of nanotechnology. Advanced Journal of Chemistry, Section A, 8(2), 378–391. https://doi.org/10.48309/ajca.2025.467077.1591
34. Theivanathan, G., Mohamed Sikkander, A., Hemavathy, N., Murukesh, & Mishra, S. R. (2022). Tactile system for visually impaired people using embedded technology. International Journal of Scientific Research and Innovative Studies, 1(1), 14–19.
35. Sikkander, A. M., RamaNachiar, R., & Yasmeen, K. (2022). Spiking neural network (SNN) using to detect breast cancer. International Journal of Scientific Research and Innovative Studies, 1(1), 20–22.
36. Sikkander, A. M., RamaNachiar, R., & Yasmeen, K. (2022). Artificial neural networks (ANNs) in lung cancer detection. International Journal of Scientific Research and Innovative Studies, 1(1), 155–158.
37. Sikk, A. M., & Abbas, H. S. (n.d.). A novel biosensor for pathogens diagnosis. https://www.alliedacademies.org/articles/a-novel-biosensor-for-pathogens-diagnosis-17372.
38. Sikkander, A. M., & Yasmeen, K. (2021). Review on nanotechnology: Curative applications in the medicinal field and its adverse effects.Journal of Science and Technology, 6(2), 1–8. https://doi.org/10.46243/jst.2021.v6.i2.pp01-08
39. Sikkander, M., Vedhi, C., & Manisankar, P. (2014). Enhanced electrochemical sensing of nimodipine with sodium montmorillonite clay. Moroccan Journal of Chemistry. https://doi.org/10.48317/imist.prsm/morjchem-v2i4.2135
40. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). AI-powered generative frameworks for the rational design of synthetic genomes and next-generation cellular architectures. World Journal of Multidisciplinary Studies, 2(12), 46–53. https://doi.org/10.65336/wjms.2025.21204
41. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). Leveraging artificial intelligence to integrate genomics, transcriptomics, and proteomics data for enhanced disease prediction. World Journal of Applied Medical Sciences, 2(12), 31–39. https://doi.org/10.65336/wjams.2025.21205
42. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). Trustworthy and transparent AI for genomic discovery.World Journal of Multidisciplinary Studies, 2(12), 39–45. https://doi.org/10.65336/wjms.2025.21203
43. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). Intelligent visualization frameworks driven by AI for multi-dimensional genomic data exploration and interpretation. World Journal of Multidisciplinary Studies, 2(12), 31–38. https://doi.org/10.65336/wjms.2025.21202
44. Sikkander, A. M., Rodrigues, J. J. P. C., Meena, M., & Abuelmakarem, H. S. (2025). AI-driven genomic biomarker discovery for precision diagnosis and personalized treatment. World Journal of Applied Medical Sciences, 2(12), 14–23. https://doi.org/10.65336/wjams.2025.21203
45. Acar, O. A., Tarakci, M., & Van Knippenberg, D. (2018). Creativity and Innovation Under Constraints: A Cross-Disciplinary Integrative Review. Journal of Management, 45(1), 96–121. https://doi.org/10.1177/0149206318805832
46. Sikkander, A. M., Rodrigues, J. J. P. C., Abuelmakarem, H. S., & Meena, M. (2025, November 28). Nanotechnology beneath: Innovations fuelling advances in acute care medicine, cardiology, oncology, and hypertension. https://wasrpublication.com/index.php/wjams/article/view/181
47. Sikkander, A. M., Rodrigues, J. J. P. C., Abuelmakarem, H. S., & Meena, M. (2025, November 26). Biomedical engineering innovations driving breakthroughs in cardiology, oncology, hypertension, and acute care medicine. https://wasrpublication.com/index.php/wjams/article/view/180
48. Sikkander, A. M., Rodrigues, J. J. P. C., Abuelmakarem, H. S., & Meena, M. (2025, November 24). AI beneath: Innovations driving breakthroughs in cardiology, oncology, hypertension, and acute care medicine. https://wasrpublication.com/index.php/wjams/article/view/179
49. Sikkander, A. M., Yadav, C. H., & Revanuri, N. (2025, November 21). Current developments in cyclophosphamide for lymphoma: Immunomodulation, metronomic approaches, and toxicity control. https://wasrpublication.com/index.php/wjams/article/view/177
50. Sikkander, A. M., Yadav, C. H., & Revanuri, N. (2025). A meta-analysis in non–small-cell lung cancer (NSCLC) indicates glucocorticoid administration is significantly associated with worse progression-free survival and overall survival for patients on ICIs. https://wasrpublication.com/index.php/wjams/article/view/176
51. Sikkander, A. R. M., Mishra, S. R., Shankaranarayanan, S., & Chegini, S. (2025). The iPSC-based models for hereditary arrhythmias: From genotype–phenotype studies to precision therapy. SPC Journal of Medical and Healthcare, 1(3), 184–191. https://doi.org/10.48309/sjmh.2025.537906.107
52. Mohamed Sikkander, A. R., Chegini, S., Mishra, S. R., & Subramanian, S. (2025). Integration of 6G networks and deep learning for advanced biomedical engineering applications: Real-time analytics, remote surgery, and intelligent healthcare systems. *SPC Journal of Medical and Healthcare, 1*(3), 167–175. https://doi.org/10.48309/sjmh.2025.537895.1073
53. Sikkander, A. R. M., Lakshmi, V. V., Theivanathan, G., & Radhakrishnan, K. (2024). Multiresolution evaluation of contourlet transform for the diagnosis of skin cancer. SSR Preprints. https://doi.org/10.21203/rs.3.rs-4778827/v1
54. Sikkander, A. M., Yasmeen, K., & Haseeb, M. (2024). Biological synthesis, characterization, and therapeutic utility of Fusarium oxysporum silver nanoparticles. SSR Preprints. https://doi.org/10.21203/rs.3.rs-4649729/v1
55. Sikkander, A. M. (2022, October 3). Nanosilicones in sub-glandular and sub-muscular implant breast transplantation. International Journal of Analytical and Applied Chemistry. https://chemical.journalspub.info/index.php?journal=JAAC&page=article&op=view&path%5B%5D=1309
56. Soni, N., & Nigam, N. (n.d.). Recent advances in artificial intelligence and machine learning: trends, challenges, and future directions. In Department of Computer Science & Engineering, Jagannath University, Jaipur, Rajasthan, India & Department of Electrical Engineering, Jagannath University, Jaipur, Rajasthan, India, International Journal of Engineering Trends and Applications (IJETA) (p. 9) [Journal-article]. https://www.ijetajournal.org/volume-12/issue-1/IJETA-V12I1P3.pdf
57. Sikkander, A. M. (2022, September 19). Assessment of basal cell carcinoma. International Journal of Chemical and Molecular Engineering. https://chemical.journalspub.info/index.php?journal=JCME&page=article&op=view&path%5B%5D=1311
58. Sikkander, A. M. (2022, September 17). Nanoemulsion in ophthalmology.International Journal of Chem-Informatics Research. https://chemical.journalspub.info/index.php?journal=JAWCM&page=article&op=view&path%5B%5D=1310
59. Sikkander, M., & Abbas, H. S. (2021). Biosensors for pathogens diagnosis. Journal of Chemical Technology Applications, 2(2), 1–3. https://www.alliedacademies.org/articles/biosensors-for-pathogens-diagnosis.pdf
60. Sikk, M., Er, A., & Yasmeen, K. (n.d.). Evaluation of surgical risk in patients with liver cancer. https://doi.org/10.35841/aaccr-5.3.115
61. Sikkander, A. M., Yadav, C. H., & Revanuri, N. (2025). Recent trends in Oncovin (vincristine) use for acute lymphoblastic leukemia: Liposomal formulations, pharmacogenomics, and toxicity-mitigation strategies. ISAR Journal of Medical and Pharmaceutical Sciences, 3(11), 20–23.
62. Sikkander, A. R. M., & Rodrigues, J. J. P. C. (2026, January 28). Machine learning models to predict chemotherapy resistance in breast cancer using single-cell sequencing. https://wasrpublication.com/index.php/wjams/article/view/219
63. Sikkander, A. R. M., & Rodrigues, J. J. P. C. (2026, January 27). Deep-learning models for ultrasound, mammography, and MRI fusion for accurate tumor segmentation. https://wasrpublication.com/index.php/wjams/article/view/218
64. Sikkander, A. M., Yadav, C. H., & Revanuri, N. (2025). Current trends: Recent innovations and impacts of flap necrosis in breast reduction. ISAR Journal of Medical and Pharmaceutical Sciences, 3(11), 12–19.
65. Razak, M. S. A., Lakshmi, V. V., & Rodrigues, J. J. P. C. (2025). Multiresolution analysis of wavelets using artificial intelligence for skin cancer detection. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.5142172
66. Razak, M. S. A., Lakshmi, V. V., Theivanathan, G., & Radhakrishnan, K. (2025). Artificial intelligence-driven multidirectional curvelet analysis for enhanced skin cancer detection. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.5127060
67. Gupta, J. K., Sikkander, A. R. M., Nagrami, F. U. H., Kumar, K., & Wahi, N. (2023). Appraisal, recent advancement, and impacts of nanomedicine in cardiac asthma. Journal of Medical Pharmaceutical and Allied Sciences, 12(5), 6132–6138. https://doi.org/10.55522/jmpas.v12i5.5214
68. Yadav, C. H., Revanuri, N., & Mohamed Sikkander, A. R. (2025). Organometallic compound phototoxicity against cancer cells. Biomedical Engineering: Applications, Basis and Communications. https://doi.org/10.4015/S1016237225500206
69. Sikkander, A. M., Ranjan, R., & Mishra, S. R. (2024). Artificial intelligence in cerebellum activation. International Journal of Cheminformatics, 1(1), 14–26. https://journals.stmjournals.com/ijci/article=2024/view=143947
70. Mohamed Sikkander, A. R., Ranjan, R., & Mishra, S. R. (2024). Nanoelectronics, nanoparticles, and nanotechnology in treatment of psychological disorders. International Journal of Environmental Chemistry. https://journals.stmjournals.com/ijec/article=2024/view=143513
71. Sikkander, A. M., Ranjan, R., & Sikkander, A. M. (2024). Organometallic osmium compounds in cancer therapy. International Journal of Advance in Molecular Engineering, 1(2), 1–25. https://journals.stmjournals.com/ijame/article=2024/view=144940
72. Mohamed Sikkander, A. R. (2024). Catalytic activity advancements in organometallic chemistry. https://engineeringjournals.stmjournals.in/index.php/JoCC/issue/view/1274
73. Gupta, J. K., Sikkander, A. R. M., Nagrami, F. U. H., Kumar, K., & Wahi, N. (2023). Appraisal, recent advancement, and impacts of nanomedicine in cardiac asthma. Journal of Medical Pharmaceutical and Allied Sciences, 12(5), 6132–6138. https://doi.org/10.55522/jmpas.v12i5.5214
74. Sikkander, A. M. (2022). Nanosilicones in sub-glandular and sub-muscular implant breast transplantation. International Journal of Analytical and Applied Chemistry. https://chemical.journalspub.info/index.php?journal=JAAC&page=index
75. Liu, D., Jiang, Y., Ma, B., & Li, L. (2025). Structure-based artificial intelligence-aided design of MYC-targeting degradation drugs for cancer therapy. Biochemical and Biophysical Research Communications, 766, 151870. https://doi.org/10.1016/j.bbrc.2025.151870
76. Zhou, G., Rusnac, DV., Park, H. et al. An artificial intelligence accelerated virtual screening platform for drug discovery. Nat Commun 15, 7761 (2024). https://doi.org/10.1038/s41467-024-52061-7
77. Murugan, N. A., Priya, G. R., Sastry, G. N., & Markidis, S. (2022). Artificial intelligence in virtual screening: Models versus experiments. Drug Discovery Today, 27(7), 1913–1923. https://doi.org/10.1016/j.drudis.2022.05.013
78. Dhakal, A., McKay, C., Tanner, J. J., & Cheng, J. (2021). Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions. Briefings in Bioinformatics, 23(1). https://doi.org/10.1093/bib/bbab476
79. Yang, R., Zhang, L., Bu, F. et al. AI-based prediction of protein–ligand binding affinity and discovery of potential natural product inhibitors against ERK2. BMC Chemistry 18, 108 (2024). https://doi.org/10.1186/s13065-024-01219-x
80. Roy, S., Nagaraj, K., Mittal, A., Shah, F. C., & Raja, K. (2025). Artificial Intelligence in Virtual Screening: Transforming Drug Research and Discovery—A review. Journal of Bio-X Research, 8. https://doi.org/10.34133/jbioxresearch.0041
81. Sikkander, A. M. (2022). Assessment of basal cell carcinoma. International Journal of Chemical and Molecular Engineering, 8(2). https://chemical.journalspub.info/index.php?journal=JCME&page=issue&op=view&path%5B%5D=273
82. Sikkander, A. M. (2022). Nanoemulsion in ophthalmology. International Journal of Chem-Informatics Research, 8(2). https://chemical.journalspub.info/index.php?journal=JAWCM&page=index
83. Sikkander, A. M. (2023). Advancement of agricultural biotechnology in USA. International Journal of AgroChemistry, 9(2). https://chemical.journalspub.info/index.php?journal=IJCPD&page=index
84. Liu, B., Zhou, H., Tan, L. et al. Exploring treatment options in cancer: tumor treatment strategies. Sig Transduct Target Ther 9, 175 (2024). https://doi.org/10.1038/s41392-024-01856-7
85. npj Precision Oncology. (2025, October 28). Nature. https://www.nature.com/npjprecisiononcology/
86. Sarkar, A., Concilio, S., Sessa, L., Marrafino, F., & Piotto, S. (2024). Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking. Results in Chemistry, 7, 101319. https://doi.org/10.1016/j.rechem.2024.101319
87. Adding a Residue to a Force Field - GROMACS 2026.1 documentation. (n.d.). https://manual.gromacs.org/documentation/2026.1/how-to/topology.html
88. Yi, J., Shi, S., Fu, L. et al. OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds. Nat Protoc 19, 1105–1121 (2024). https://doi.org/10.1038/s41596-023-00942-4
89. Zhang, C., Liu, Y., Li, G., Yang, Z., Han, C., Sun, X., Sheng, C., Ding, K., & Rao, Y. (2024). Targeting the undruggables—the power of protein degraders. Science Bulletin, 69(11), 1776–1797. https://doi.org/10.1016/j.scib.2024.03.056
90. Das, U. (2025). Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science. Medicine in Drug Discovery, 27, 100213. https://doi.org/10.1016/j.medidd.2025.100213
91. Chun, M., & Chun, M. (2025, July 23). How Artificial Intelligence is Revolutionizing Drug Discovery - Petrie-Flom Center. Petrie-Flom Center - The blog of the Petrie-Flom Center at Harvard Law School. https://petrieflom.law.harvard.edu/2023/03/20/how-artificial-intelligence-is-revolutionizing-drug-discovery/
92. Niazi, S. K. (2025). Artificial Intelligence in Small-Molecule Drug Discovery: A Critical Review of Methods, Applications, and Real-World Outcomes. Pharmaceuticals, 18(9), 1271. https://doi.org/10.3390/ph18091271
93. Niazi, S.K.; Mariam, Z. Artificial intelligence in drug development: Reshaping the therapeutic landscape. Ther. Adv. Drug. Saf. 2025, 16, 20420986251321704.
94. Niazi, S.K.; Mariam, Z. Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals 2023, 17, 22.
95. Ren, F.; Aliper, A.; Chen, J.; Zhao, H.; Rao, S.; Kuppe, C.; Ozerov, I.V.; Zhang, M.; Witte, K.; Kruse, C.; et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat. Biotechnol. 2025, 43, 63–75.
96. Mullowney, M.W.; Duncan, K.R.; Elsayed, S.S.; Garg, N.; van der Hooft, J.J.J.; Martin, N.I.; Meijer, D.; Terlouw, B.R.; Biermann, F.; Blin, K.; et al. Artificial intelligence for natural product drug discovery. Nat. Rev. Drug Discov. 2023, 22, 895–916.
97. Niazi, S.K. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives. Drug Des. Devel. Ther. 2023, 17, 2691–2725.
98. Niazi, S.K. Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments. Pharmaceuticals 2025, 18, 901.
99. Singh, R.; Paxton, M.; Auclair, J. Regulating the AI-enabled ecosystem for human therapeutics. Commun. Med. 2025, 5, 181.
100. Wang, Xy., Chen, Y., Li, Yf. et al. Advancing active compound discovery for novel drug targets: insights from AI-driven approaches. Acta Pharmacol Sin 46, 2865–2876 (2025). https://doi.org/10.1038/s41401-025-01591-x
101. Wang, L., Song, Y., Wang, H., Zhang, X., Wang, M., He, J., Li, S., Zhang, L., Li, K., & Cao, L. (2023). Advances of Artificial Intelligence in Anti-Cancer Drug Design: A review of the past decade. Pharmaceuticals, 16(2), 253. https://doi.org/10.3390/ph16020253
102. Venturini, J., Chakraborty, A., Baysal, M.A. et al. Developments in nanotechnology approaches for the treatment of solid tumors. Exp Hematol Oncol 14, 76 (2025). https://doi.org/10.1186/s40164-025-00656-1
103. Zhang, R., Wen, H., Lin, Z., Li, B., & Zhou, X. (2025). Artificial Intelligence-Driven Drug Toxicity Prediction: Advances, challenges, and future Directions. Toxics, 13(7), 525. https://doi.org/10.3390/toxics13070525
